15+ studies — an honest read of the evidence
Strong where SofPulse is cleared, mixed elsewhere. We stay in the lane.
Where it's strong
Post-operative pain, edema, and inflammation in soft tissue — SofPulse's actual FDA-cleared indication — is supported by multiple double-blind, placebo-controlled trials with a coherent biological mechanism. PEMF for bone healing (non-union fractures, spinal fusion) has decades of FDA-cleared use behind it. The 15+ studies referenced across this site cluster exactly here.
Where it's mixed or weak
For several chronic conditions — knee osteoarthritis and chronic low-back pain among them — systematic reviews are inconsistent, and at least one review found little benefit in knee OA. We don't make those claims. Across the broader PEMF field, many trials are small, use widely varying signal parameters, and face the genuine difficulty of building a truly indistinguishable sham — so evidence certainty varies by indication.
The honest summary
SofPulse is on its firmest ground exactly where it is cleared and billed — post-surgical recovery and CMS-covered wound healing. That is the story this site tells, and nothing beyond it.
How to read the evidence hierarchy
The strongest evidence in this library comes from two double-blind, placebo-controlled RCTs (Rhode 2010; Heden & Pilla 2008). These are the studies where the sham device was indistinguishable from the active device — the methodological gold standard for separating a real biological effect from expectation. Below that tier sit controlled clinical studies without blinding, experimental mechanistic studies, and monitoring data. Each piece of evidence is labeled for what it is. Where the study design is not a blinded RCT, that is stated explicitly.
What the boundaries protect
Every claim on this site that stays within the FDA-cleared indication and the peer-reviewed evidence base is defensible — to a patient, a payer, a hospital medical committee, or a regulator. Claims that venture beyond the cleared indication or into evidence categories where the PEMF literature is genuinely mixed are not made, because they would undermine the credibility of every other claim. The honest boundaries are not a weakness — they are the foundation of trust with the prescribers and patients the channel needs to reach.
Sources
- Systematic reviews of PEMF in knee OA and chronic low-back pain
- GRADE evidence-certainty assessments
Related
Ready to put SofPulse to work?
SofPulse is available by prescription. Patients can order online and pay with pre-tax HSA/FSA dollars; clinicians can start prescribing in minutes.
For education only — not medical advice, and not a substitute for a clinician's judgment. SofPulse is available by prescription only. Reimbursement figures reflect the 2026 CMS Physician Fee Schedule and vary by locality, payer, and documentation.